Nivolumab is already approved for use in cases of melanoma, renal cancer, Hodgkin lymphoma and a form of cancer affecting the head and neck, and has now been approved for lung cancer.

The Health Service Executive (HSE) has recommended the use of the potentially life-extending cancer drug nivolumab (sold as Opdivo) for patients with (...)

Dr Michaela Higgins, consultant oncologist.

‘There are many treatment options and choices available for breast cancer,” says consultant oncologist Dr Michaela Higgins. She is addressing this wee(...)